Immunotherapy

Papers
(The H4-Index of Immunotherapy is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Simulating a virtual tumor board with large language models: a pilot study in NSCLC patients receiving immunotherapy110
Imaging of brain metastases treated with immune checkpoint inhibitors38
Uric acid level in metastatic renal cell carcinoma treated with nivolumab: a Turkish Oncology Group Kidney Cancer Consortium (TKCC) study29
Atezolizumab and Bevacizumab prior to liver transplantation in hepatic angiosarcoma mimicking hepatocellular carcinoma28
Cost–Effectiveness Analysis of Serplulimab as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma23
Identifying risk factors and biomarkers for severe CIP in lung cancer patients– a retrospective case series study22
Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer Without Tumor Pd-L1 Expression in Asia22
Real-World Outcomes with Immuno-Oncology Therapies in Advanced Melanoma: Final Results of the OPTIMIzE Registry Study22
Postvaccination immune-mediated hepatitis: what do we really know?21
Pembrolizumab in patients from China with microsatellite instability-high/mismatch repair deficient tumors: KEYNOTE-15820
Targeting PD-1/PD-L1 in Biliary Tract Cancer: Role and Available Data20
Diagnostic and therapeutic evaluation of Blomia tropicalis in patients with allergic rhinitis19
Pd-1, Pd-L1, Ido, Cd70 and Microsatellite Instability as Potential Targets to Prevent Immune Evasion in Sarcomas19
MicroRNA prognostic markers for immune checkpoint inhibitor success in urologic cancers18
The role of bronchoscopic cryoimmunotherapy in non-small cell lung cancer: current evidence and future perspectives18
Nivolumab induced discolouration of the tongue: a case report18
Therapeutic lymph node dissection with neoadjuvant immunotherapy for macroscopic melanoma – too much skin in the game?18
4-1BB Antibody Enhances Cytotoxic Activity of Natural Killer Cells Against Prostate Cancer Cells Via NKG2D Agonist Combined with IL-2717
0.12662220001221